Home > Insider Trading > Filing (0001144204-10-065071)

Filing Details

Accession Number:: 0001144204-10-065071
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-06 19:50:41
Reporting Period:: 2010-12-02

Filing Date:: 2010-12-06
Accepted Time:: 2010-12-06 19:50:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1434718	Iii F James Oliviero	C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2010-12-02	107,623	$5.01	249,209	No	4	S	Direct
Common Stock	Disposition	2010-12-03	24,150	$5.06	225,059	No	4	S	Direct
Common Stock	Disposition	2010-12-06	3,600	$5.00	221,459	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Reflects the weighted average sale price. The range of prices for such transactions is $5.00 to $5.09. The reporting person effected multiple same-way open market sales transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 249,209 shares, 221,459 are shares of restricted stock. In addition, Mr. Oliviero holds stock options to purchase up to 198,000 shares of common stock, of which 190,813 stock options are vested and exercisable.
Reflects the weighted average sale price. The range of prices for such transactions is $5.05 to $5.10. The reporting person effected multiple same-way open market sales transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 225,059 shares, 221,459 are shares of restricted stock. In addition, Mr. Oliviero holds stock options to purchase up to 198,000 shares of common stock, of which 190,813 stock options are vested and exercisable.
Of the 221,459 shares, 221,459 are shares of restricted stock. In addition, Mr. Oliviero holds stock options to purchase up to 198,000 shares of common stock, of which 190,813 stock options are vested and exercisable.